Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Aspira Women's Health Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 58 | 2 | 47 | −9 |
| Shares | 12.0M | 430.7K | 9.73M | −1.84M (−15.9%) |
| Value | $4.46M | $160.1K | $3.24M | −$1.07M (−24.8%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Aspira Women's Health Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Belpointe Asset Management LLC | 153,435 | $51.0K | 0.00% |
| DFPG Investments, LLC | 20,590 | $9.25K | 0.00% |
| Virtu Financial LLC | 19,150 | $6.00K | 0.00% |
| Jane Street Group, LLC | 13,027 | $4.33K | 0.00% |
| UBS Group AG | 5,718 | $1.89K | 0.00% |
Sold out (14)
Institutions that held Aspira Women's Health Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wealthstream Advisors, Inc. | 235,304 | $88.0K |
| Goldman Sachs Group Inc | 82,610 | $31.0K |
| Qube Research & Technologies Ltd | 65,279 | $24.0K |
| Occudo Quantitative Strategies LP | 51,995 | $19.0K |
| Schonfeld Strategic Advisors LLC | 39,100 | $14.0K |
| LMR Partners LLP | 34,576 | $13.0K |
| Cornerstone Advisory, LLC | 33,250 | $12.0K |
| Man Group plc | 23,509 | $9.00K |
| Two Sigma Securities, LLC | 16,903 | $6.00K |
| BNP Paribas Arbitrage, SA | 11,562 | $4.30K |
| Envestnet Asset Management Inc | 11,334 | $4.00K |
| Verition Fund Management LLC | 10,249 | $4.00K |
| Clearstead Advisors, LLC | 7,430 | $3.00K |
| FMR LLC | 484 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Aspira Women's Health Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 417,123 | $155.0K |
| American Portfolios Advisors | 13,592 | $5.06K |